相关实验视频
Updated: Jul 11, 2025

09:29
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder
Published on: January 9, 2015
15.5K
检查冲动控制障碍与在帕金森病中使用抗抑郁药物之间的联系
Christopher B Morrow1, Jared T Hinkle1, Joseph Seemiller2
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, USA.
Parkinsonism & related disorders
|November 3, 2023
概括
帕金森病的冲动控制障碍与药物状态之间的更大的情绪变化有关. 抗抑郁药的使用也可能与这些疾病有关.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 中的冲动控制障碍 (ICD) 与双相情感障碍的症状相同,这表明有共同的神经生物学基础.
- 研究情感症状,药物状态和PD中的ICD之间的关系对于了解疾病机制至关重要.
研究的目的:
- 测试是否更大的情感症状变化从OFF到ON的药物状态与PD中的ICD有关.
- 为了检查是否抗抑郁药暴露与PD患者更大的情感症状波动和ICD有关.
主要方法:
- 200名患有帕金森病的参与者被评估在"关闭"和"启动"多巴胺药物状态.
- 汉密尔顿焦虑和抑郁评分表测量了情感症状;统计测试比较了结果.
- 多变量逻辑回归分析了抗抑郁药使用与ICD之间的关联.
主要成果:
- 患有ICD的个体表现出更严重的焦虑和抑郁,以及在药物状态之间更大的抑郁症状变化.
- 抗抑郁药的使用与更高的焦虑和抑郁症得分以及更大的焦虑症状变化相关.
- 抗抑郁药的使用显着与ICD的几率增加有关 (OR2.3,p=0.04).
结论:
- 情感症状严重程度和"开启"和"关闭"多巴胺状态的波动与帕金森病中的ICD有关.
- 抗抑郁药物治疗可能与ICD的出现或恶化有关.
- 需要进一步的研究来澄清抗抑郁药治疗和ICD发展之间的时间关系.
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
410
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
410
Attention-Deficit/Hyperactivity Disorder
69
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
69
Antidepressant Drugs: Overview
524
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
524

